Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Treasury Shares (2020 - 2025)

AC Immune has reported Treasury Shares over the past 6 years, most recently at -$272755.0 for Q4 2025.

  • Quarterly Treasury Shares fell 9.61% to -$272755.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$272755.0 through Dec 2025, down 9.61% year-over-year, with the annual reading at -$272755.0 for FY2025, 9.61% down from the prior year.
  • Treasury Shares was $955.7 billion for Q4 2025 at AC Immune, up from $939.2 billion in the prior quarter.
  • Over five years, Treasury Shares peaked at $1131.6 billion in Q4 2023 and troughed at $939.2 billion in Q4 2024.
  • The 3-year median for Treasury Shares is $955.7 billion (2025), against an average of $1008.8 billion.
  • Year-over-year, Treasury Shares plummeted 124215.44% in 2021 and then soared 100.1% in 2022.
  • A 5-year view of Treasury Shares shows it stood at -$134.5 million in 2021, then soared by 100.1% to $128714.7 in 2022, then crashed by 92064.79% to -$118.4 million in 2023, then soared by 99.79% to -$248851.8 in 2024, then decreased by 9.61% to -$272755.0 in 2025.
  • Per Business Quant, the three most recent readings for ACIU's Treasury Shares are -$272755.0 (Q4 2025), -$272523.9 (Q3 2025), and -$263320.1 (Q2 2025).